UROMED CORP
SC 13D/A, 1998-03-06
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: TALX CORP, SC 13G, 1998-03-06
Next: VASTAR RESOURCES INC, 10-K405, 1998-03-06



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 4)*


                               UROMED CORPORATION
                         ------------------------------
                                (Name of Issuer)

                           Common Stock, No Par Value
                         ------------------------------
                         (Title of Class of Securities)

                                    917274102
                               ------------------
                                 (CUSIP Number)

                              Stephen M. Vine, Esq.
                    Akin, Gump, Strauss, Hauer & Feld, L.L.P.
                               590 Madison Avenue
                            New York, New York 10022
                                 (212) 872-1000
                      ------------------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                  March 4, 1998
                              -------------------
                      (Date of Event which Requires Filing
                               of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_].

Note: Six copies of this statement, including all exhibits, should be filed with
the  Commission.  See Rule 13d- 1(a) for other  parties to whom copies are to be
sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter disclosure
provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                         Continued on following page(s)
                                Page 1 of 8 Pages




<PAGE>


                                                               Page 2 of 8 Pages




                                  SCHEDULE 13D

CUSIP No. 917274102

1        Name of Reporting Person
         I.R.S. Identification No. of Above Persons (ENTITIES ONLY)

                  Soros Capital, L.P.

2        Check the Appropriate Box If a Member of a Group*
                                                     a.  [_]
                                                     b.  [x]
3        SEC Use Only

4        Source of Funds*

                  Not applicable

5        Check Box If Disclosure of Legal  Proceedings  Is Required  Pursuant to
         Items 2(d) or 2(e) [_]

6        Citizenship or Place of Organization

                  Bermuda

                           7        Sole Voting Power
 Number of                                  1,330,254
   Shares
Beneficially               8        Shared Voting Power
  Owned By                                  0
    Each
  Reporting                9        Sole Dispositive Power
   Person                                   1,330,254
    With
                           10       Shared Dispositive Power
                                            0

11       Aggregate Amount Beneficially Owned by Each Reporting Person

                                            1,330,254

12       Check Box If the Aggregate Amount in Row (11) Excludes Certain
         Shares*                                       [_]

13       Percent of Class Represented By Amount in Row (11)

                                    4.99%

14       Type of Reporting Person*

                  PN

                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

<PAGE>



                                                               Page 3 of 8 Pages



                                  SCHEDULE 13D

CUSIP No. 917274102

1        Name of Reporting Person
         I.R.S. Identification No. of Above Persons (ENTITIES ONLY)

                  Soros Fund Management LLC

2        Check the Appropriate Box If a Member of a Group*
                                                     a.  [_]
                                                     b.  [x]
3        SEC Use Only

4        Source of Funds*

                  Not applicable

5        Check Box If Disclosure of Legal  Proceedings  Is Required  Pursuant to
         Items 2(d) or 2(e) [_]

6        Citizenship or Place of Organization

                  Delaware

                           7        Sole Voting Power
 Number of                                  1,330,254
   Shares
Beneficially               8        Shared Voting Power
  Owned By                                  0
    Each
  Reporting                9        Sole Dispositive Power
   Person                                   1,330,254
    With
                           10       Shared Dispositive Power
                                            0

11       Aggregate Amount Beneficially Owned by Each Reporting Person

                                            1,330,254

12       Check Box If the Aggregate Amount in Row (11) Excludes Certain
         Shares*                                       [_]

13       Percent of Class Represented By Amount in Row (11)

                                    4.99%

14       Type of Reporting Person*

                  OO; IA


                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

<PAGE>



                                                               Page 4 of 8 Pages



                                  SCHEDULE 13D

CUSIP No. 917274102

1        Name of Reporting Person
         I.R.S. Identification No. of Above Persons (ENTITIES ONLY)

                  George Soros (in the capacity described herein)

2        Check the Appropriate Box If a Member of a Group*
                                                     a.  [_]
                                                     b.  [x]

3        SEC Use Only

4        Source of Funds*

                  Not applicable

5        Check Box If Disclosure of Legal  Proceedings  Is Required  Pursuant to
         Items 2(d) or 2(e) [_]

6        Citizenship or Place of Organization

                  United States

                           7        Sole Voting Power
 Number of                                  0
   Shares
Beneficially               8        Shared Voting Power
  Owned By                                  1,330,254
    Each
  Reporting                9        Sole Dispositive Power
   Person                                   0
    With
                           10       Shared Dispositive Power
                                            1,330,254

11       Aggregate Amount Beneficially Owned by Each Reporting Person

                                            1,330,254

12       Check Box If the Aggregate Amount in Row (11) Excludes Certain
         Shares*                                              [_]

13       Percent of Class Represented By Amount in Row (11)

                                    4.99%

14       Type of Reporting Person*

                  IA


                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

<PAGE>



                                                               Page 5 of 8 Pages



                                  SCHEDULE 13D

CUSIP No. 917274102

1        Name of Reporting Person
         I.R.S. Identification No. of Above Persons (ENTITIES ONLY)

                  Stanley F. Druckenmiller (in the capacity described herein)

2        Check the Appropriate Box If a Member of a Group*
                                                     a.  [_]
                                                     b.  [x]
3        SEC Use Only

4        Source of Funds*

                  Not applicable

5        Check Box If Disclosure of Legal  Proceedings  Is Required  Pursuant to
         Items 2(d) or 2(e) [_]

6        Citizenship or Place of Organization

                  United States

                           7        Sole Voting Power
 Number of                                  0
   Shares
Beneficially               8        Shared Voting Power
  Owned By                                  1,330,254
    Each
  Reporting                9        Sole Dispositive Power
   Person                                   0
    With
                           10       Shared Dispositive Power
                                            1,330,254

11       Aggregate Amount Beneficially Owned by Each Reporting Person

                                            1,330,254

12       Check Box If the Aggregate Amount in Row (11) Excludes Certain
         Shares*                                              [_]

13       Percent of Class Represented By Amount in Row (11)

                                    4.99%

14       Type of Reporting Person*

                  IA


                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

<PAGE>



                                                               Page 6 of 8 Pages




               This  Amendment No. 4 to Schedule 13D relates to shares of Common
Stock, no par value (the "Shares"),  of UroMed Corporation (the "Issuer").  This
Amendment  No. 4  supplementally  amends the initial  statement  on Schedule 13D
dated April 15, 1994 and all  amendments  thereto  (collectively,  the  "Initial
Statement")  filed by one of the  Reporting  Persons (as defined  herein).  This
Amendment  No.  4 is  being  filed  to  report  that  as a  result  of a  recent
disposition  of  Shares,  the  Reporting  Persons  may no longer  be deemed  the
beneficial  owners  of five  percent  or more of the  outstanding  Shares of the
Issuer.  Capitalized  terms used  herein but not defined  herein  shall have the
meanings  given to them in the  Initial  Statement.  The  Initial  Statement  is
supplementally amended as follows.

Item 2.        Identity and Background.

               This  statement is being filed on behalf of Soros Capital L.P., a
Bermuda  limited  partnership  ("Soros  Capital"),  Soros Fund Management LLC, a
Delaware limited liability  company ("SFM LLC"), Mr. George Soros ("Mr.  Soros")
and Mr. Stanley F. Druckenmiller  ("Mr.  Druckenmiller,  and together with Soros
Capital, SFM LLC and Mr. Soros, the "Reporting Persons"). This Statement relates
to Shares held for the account of Soros Capital.

               Updated information  concerning the Managing Directors of SFM LLC
is attached hereto as Annex A and incorporated herein by reference.

Item 5.        Interest in Securities of the Issuer.

               (a)  Each of the Reporting  Persons may be deemed the  beneficial
owner  of  the   1,330,254   Shares  held  for  the  account  of  Soros  Capital
(approximately 4.99% of the total number of Shares outstanding).

               (b)  (i) Pursuant to the  agreement  between Mr.  Steven  Gilbert
("Mr. Gilbert"), the managing general partner of Soros Capital, and SFM LLC, SFM
LLC may be deemed to have sole power to direct the voting and disposition of the
1,330,254 Shares held for the account of Soros Capital.

                    (ii) Pursuant to the agreement  between Mr.  Gilbert and SFM
LLC and as a result of the  positions  held by Mr.  Soros and Mr.  Druckenmiller
with SFM LLC,  each of Mr.  Soros  and Mr.  Druckenmiller  may be deemed to have
shared power to direct the voting and  disposition of the 1,330,254  Shares held
for the account of Soros Capital.

               (c)  Except for the sale of 50,000 Shares at a price of $2.61 per
Share on March 4, 1998 and for the sale of 2,000  Shares at a price of $2.61 per
Share on March 5, 1998, which were executed in routine brokerage transactions on
the  over-the-counter  market,  there have been no  transactions  effected  with
respect to the Shares  since  January 5, 1998 (60 days prior to the date hereof)
by any of the Reporting Persons.

               (d)  The partners of Soros Capital have the right to  participate
in the receipt of dividends from, or proceeds from the sale of,  securities held
by  Soros  Capital  (including  the  Shares)  in  accordance  with  their  share
partnership interests in Soros Capital.

               (e)  Each of the Reporting  Persons  ceased to be the  beneficial
owner of more than 5% of the Shares on March 4, 1998.




<PAGE>



                                                               Page 7 of 8 Pages



                                   SIGNATURES

               After  reasonable  inquiry  and to the best of my  knowledge  and
belief,  the  undersigned  certifies  that  the  information  set  forth in this
statement is true, complete and correct.

Date:  March 6, 1998


                                        SOROS FUND MANAGEMENT LLC

                                        By:  /S/ MICHAEL C. NEUS
                                             ----------------------------------
                                             Michael C. Neus
                                             Assistant General Counsel


                                        GEORGE SOROS

                                        By:  /S/ MICHAEL C. NEUS
                                             ----------------------------------
                                             Michael C. Neus
                                             Attorney-in-Fact


                                        STANLEY F. DRUCKENMILLER

                                        By:  /S/ MICHAEL C. NEUS
                                             ----------------------------------
                                             Michael C. Neus
                                             Attorney-in-Fact


                                        SOROS CAPITAL, L.P.

                                        By:  /S/ JOHN MCEVOY
                                             ----------------------------------
                                             John McEvoy
                                             Attorney-in-Fact



<PAGE>



                                                               Page 8 of 8 Pages


                                     ANNEX A


               The following is a list of all of the persons (other than Stanley
Druckenmiller) who serve as Managing Directors of SFM LLC:


                               Scott K. H. Bessent
                                 Walter Burlock
                                Brian J. Corvese
                               Jeffrey L. Feinberg
                                  Arminio Fraga
                                 Gary Gladstein
                                    Ron Hiram
                                Robert K. Jermain
                                 David N. Kowitz
                               Alexander C. McAree
                                  Paul McNulty
                              Gabriel S. Nechamkin
                                   Steven Okin
                                  Dale Precoda
                               Lief D. Rosenblatt
                                 Mark D. Sonnino
                             Filiberto H. Verticelli
                                 Sean C. Warren

Each of the  above-listed  persons is a United States  citizen  whose  principal
occupation  is serving as Managing  Director of SFM LLC, and each has a business
address c/o Soros Fund Management LLC, 888 Seventh Avenue, 33rd Floor, New York,
New York 10106.

To the best of the Reporting Persons' knowledge:

         (a)  None of the above persons holds any Shares.
         (b)  None  of  the  above  persons  has  any  contracts,  arrangements,
understandings or relationships with respect to the Shares.







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission